Markets:

Overview

News

Currencies

International

Treasuries

Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

170.69 -1.19 (-0.69%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Axsome Therapeutics, Inc. - Common Stock

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Why Bed Bath & Beyond Is Trading Lower By Over 40%, Here Are 55 Stocks Moving In Friday's Mid-Day Session ↗

August 19, 2022

Gainers GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatility following the company's IPO on Thursday.

Via Benzinga

How Is The Market Feeling About Axsome Therapeutics? ↗

August 19, 2022

Axsome Therapeutics's (NASDAQ:AXSM) short percent of float has fallen 3.86% since its last report. The company recently reported that it has 5.75 million shares sold short, which...

Via Benzinga

Nasdaq Dips 250 Points; Crude Oil Moves Higher ↗

August 19, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 250 points on Friday.

Via Benzinga

Why Is Axsome Therapeutics (AXSM) Stock Up 30% Today? ↗

August 19, 2022

Biopharmaceutical company AXSM stock is getting a huge lift from news the FDA has approved its depression treatment.

Via InvestorPlace

Axsome's Depression Candidate Scores FDA Nod, Stock Surges To 52-High ↗

August 19, 2022

Via Benzinga

Axsome Therapeutics: Q2 Earnings Insights ↗

August 09, 2022

Axsome Therapeutics (NASDAQ:AXSM) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Here's How Much You Would Have Made Owning Axsome Therapeutics Stock In The Last 5 Years ↗

August 19, 2022

Axsome Therapeutics (NASDAQ:AXSM) has outperformed the market over the past 5 years by 52.74% on an annualized basis producing an average annual return of 64.23%. Currently, Axsome Therapeutics has a...

Via Benzinga

General Motors, Foot Locker And Some Other Big Stocks Recording Gains On Friday ↗

August 19, 2022

GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatility following the company's IPO on Thursday.

Via Benzinga

GCT Stock Alert: What Is Going on With GigaCloud Technology Today? ↗

August 19, 2022

GigaCloud Technology (GCT) stock is continuing to rally on Friday after the Hong Kong-based fintech company launched its IPO yesterday.

Via InvestorPlace

Why Is Volcon (VLCN) Stock Up 56% Today? ↗

August 19, 2022

Volcon (VLCN) stock is rocketing higher on Friday after the EV company revealed massive pre-production orders for its Stag.

Via InvestorPlace

Dow Falls Over 200 Points; Deere Earnings Miss Estimates ↗

August 19, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 200 points on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 19, 2022

Via Benzinga

Axsome Shares Shoot Higher As FDA Approves Major Depressive Disorder Candidate ↗

August 19, 2022

The U.S. Food and Drug Administration (FDA) has approved Axsome Therapeutics’ (NASDAQ: AXSM) lead asset AUVELITY (dextromethorphan HBr -bupropion HCl) extended-release tablets for the treatment of...

Via Benzinga

Covid Exposed A 'Brain Health Pandemic' — Here's How Biotech Stocks Like Biogen, Sage Therapeutics Could Help ↗

August 11, 2022

Today's depression drugs don't fit many patients' needs. Biotech companies may change that.

Via Investor's Business Daily

What 4 Analyst Ratings Have To Say About Axsome Therapeutics ↗

August 10, 2022

Axsome Therapeutics (NASDAQ:AXSM) has observed the following analyst ratings within the last quarter:

Via Benzinga

Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful ↗

August 09, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

7 Small-Cap Growth Stocks With 1,000% Upside Potential ↗

July 31, 2022

Here're 7 small-cap growth stocks with 1,000% upside potential. ACLS, AXSM, GBT, GPRO, HCAT, SKLZ, and VERU can make great investments.

Via InvestorPlace

Biotech Investors: August's Key PDUFA Catalysts You Must Know ↗

July 31, 2022

Regulatory decisions have yet to pick up pace this year. July’s calendar was light, but the good news was that most decisions turned out to be positive. That said, none of the drugs approved during the...

Via Benzinga

AXSOME THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Axsome Therapeutics, Inc. - AXSM

July 30, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Axsome Therapeutics to Report Second Quarter 2022 Financial Results on August 9, 2022

July 28, 2022

From Axsome Therapeutics, Inc.

Via GlobeNewswire

7 Biotech Stocks to Buy for Q3 ↗

July 18, 2022

These biotech stocks could be good buys due for a few reasons, including great R&D pipelines and treatments with promising market potential.

Via InvestorPlace

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Axsome Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

July 12, 2022

From The Schall Law Firm

Via Business Wire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Axsome Therapeutics, Inc. (AXSM)

July 11, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Axsome Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

July 11, 2022

From The Schall Law Firm

Via Business Wire

AXSOME DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Axsome Therapeutics, Inc. and Encourages Investors to Contact the Firm

July 08, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

NASDAQ:AXSM Investor Notice: Deadline on July 12, 2022 in Lawsuit Against Axsome Therapeutics, Inc. ↗

July 08, 2022

San Diego, CA -- (SBWIRE) -- 07/08/2022 -- The Shareholders Foundation announced that a deadline is coming up on July 12, 2022 in the lawsuit filed for certain investors of Axsome Therapeutics, Inc....

Via SBWire

Do You Have Biotech FOMO? It Might Be Time To Pay Attention To These Names ↗

July 06, 2022

Biotech stocks continued going gangbusters Wednesday. Here's why, experts say.

Via Investor's Business Daily

Do You Have Biotech FOMO? Why Cogent, Arvinas And Others Are Flying ↗

July 06, 2022

Biotech stocks continued going gangbusters Wednesday. Here's why, experts say.

Via Investor's Business Daily

ROSEN, A LEADING LAW FIRM, Encourages Axsome Therapeutics, Inc. Investors with Losses Over $100K to Secure Counsel Before Important July 12 Deadline in Securities Class Action - AXSM

July 04, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

ROSEN, A LEADING NATIONAL FIRM, Encourages Axsome Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important July 12 Deadline in Securities Class Action - AXSM

June 29, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.